Retatrutide
Chemical Formula: C221H342N46O68
Tri-agonist receptor map
RUO catalog listing with tri-agonist receptor annotations, sequence identity details, and lot-linked verification records.
Opening Statement
Real research peptides at real research prices.
Real research peptides at real research prices means a lab-first catalog with sequence-level metadata, RUO controls, and clear batch documentation from listing to checkout.
For teams sourcing research peptides in the U.S., we emphasize repeatable procurement workflows with COA verification, ingredient dossiers, and lot traceability instead of promotional claim language.
Catalog Library
Research materials listed with pathway context and batch traceability
BPC-157
Chemical Formula: C62H98N16O22
Peptide identity and assay tracking
Sequence-defined entry with reconstitution workflow notes and batch documentation checkpoints for repeatable lab prep.
GHK-Cu
Chemical Formula: C14H22CuN6O4
Copper peptide complex map
Copper tripeptide listing with complex-state context, identity metadata, and handling guidance for QC consistency.
Melanotan I
Chemical Formula: C78H111N21O19
Melanocortin pathway model
Melanocortin class profile with sequence notation and receptor-family references for controlled comparison work.
Melanotan II
Chemical Formula: C50H69N15O9
Melanocortin analog profile
Analog-specific metadata set built for cross-lot interpretation discipline and assay-to-assay repeatability checks.
Ipamorelin
Chemical Formula: C38H49N9O5
Sequence and receptor annotation
GHSR-oriented reference entry pairing sequence notation with handling boundaries and lot traceability context.
Bacteriostatic Water
Chemical Formula: N/A
Reconstitution support profile
Research diluent listing with preservative composition details and preparation notes for consistent protocol setup.
Batch Transparency Portal
View & Verify monthly batch's COA's
Peptide Batches Viewer
Ingredient Transparency Table
Expand citations to inspect source references and profile details
| Ingredient | Mechanistic Rationale | Pathway Summary | Research |
|---|---|---|---|
| Retatrutide | Tri-agonist research peptide documented with receptor mapping, sequence traceability, and assay-linked batch records. | Tri-agonist receptor map | |
| BPC-157 | Sequence-defined research peptide cataloged with lot traceability and controlled reconstitution guidance for repeatable assays. | Peptide identity and assay tracking | |
| GHK-Cu | Copper-peptide complex documented with peptide and ion-state metadata plus handling controls for reproducible analyses. | Copper peptide complex map | |
| Melanotan I | Melanocortin-targeting research peptide cataloged with sequence identifiers and receptor-class annotations for assay repeatability. | Melanocortin pathway model | |
| Melanotan II | Melanocortin analog cataloged with sequence-level metadata and standardized receptor mapping to reduce cross-lot interpretation drift. | Melanocortin analog profile | |
| Ipamorelin | Research peptide cataloged with sequence notation, receptor-family labeling, and traceable handling boundaries for analytical consistency. | Sequence and receptor annotation | |
| Bacteriostatic Water | Reconstitution diluent documented with composition and preservative metadata to standardize peptide preparation context. | Reconstitution support profile |
Evidence Hierarchy
Claims follow ranked evidence, not marketing copy
I
Controlled Outcomes
Confidence: Highest
Controlled outcome data weighted highest for evidence ranking.
II
Mechanistic
Confidence: Contextual
Pathway and receptor-level evidence used when outcome data is limited.
III
Preclinical
Confidence: Low transfer
Directional only. Not used alone for final catalog decisions.
IV
Observational
Confidence: Minimal
Logged but explicitly separated from evidence-backed catalog choices.
Learning Center
Operational guides for RUO procurement, COA review, and batch traceability
Explore practical documentation standards, glossary references, and quality-review checklists built for research teams.
Open the Learning Center or start with COA verification guidance.
Research Limitations